Palo Alto Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Palo Alto Wealth Advisors's LLY Position: Q3 2025 in Review
Palo Alto Wealth Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q3 2025, buying an estimated $13.4K and bringing the position to 726 shares worth $717K. The position accounts for 0.21% of the portfolio, ranked #30.
Palo Alto Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Palo Alto Wealth Advisors held 726 shares of Eli Lilly worth $717K as of Q3 2025.
- Palo Alto Wealth Advisors bought 18 Eli Lilly shares in Q3 2025, an estimated $13.4K.
- Eli Lilly made up 0.21% of Palo Alto Wealth Advisors's portfolio in Q3 2025, its #30 holding.
- Palo Alto Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
- 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Palo Alto Wealth Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.